Skip to content
Disclosery

DIADEMA PARTNERS LP

Follow

13F filer, CIK 2026172, MORRISTOWN, NJ

DIADEMA PARTNERS LP reported $791,347,834 across 149 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 62.47% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001892688-26-000119

Period
2026-06-30
Reported value
$791M
Holdings
149
Top 10 weight
62.47%
New
69
Sold out
64

Largest buys vs the previous quarter

SecurityShares changeApprox. value
UTHRadded+25,686$13.9M
ABVXadded+87,700$11.6M
EWTXnew+272,214$11.1M
RVMDadded+58,346$10.9M
BMRNadded+164,617$9.42M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BRIDGEBIO PHARMA INCexited-250,000-$18.6M
JAZZexited-54,755-$10.4M
TERNexited-181,752-$9.58M
JNJreduced-31,771-$8.07M
INCYexited-78,029-$7.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001892688-26-000119, largest first. % of portfolio is the value over $283,170,561, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,000 shares; 2026Q1: 27,303 shares; 2026Q2: 52,989 shares 52,989$28.7M10.14%+25,686Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 79,079 shares; 2025Q3: 59,079 shares; 2025Q4: 37,020 shares; 2026Q1: 80,872 shares; 2026Q2: 139,218 shares 139,218$26.1M9.21%+58,346Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,620 shares; 2025Q4: 75,644 shares; 2026Q1: 75,944 shares; 2026Q2: 163,644 shares 163,644$21.6M7.63%+87,700Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 90,000 shares; 2025Q1: 392,213 shares; 2025Q2: 392,213 shares; 2025Q3: 97,813 shares; 2025Q4: 131,852 shares; 2026Q1: 322,764 shares; 2026Q2: 493,664 shares 493,664$19.1M6.75%+170,900Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 52,877 shares; 2025Q2: 192,877 shares; 2025Q3: 212,877 shares; 2025Q4: 146,361 shares; 2026Q1: 148,229 shares; 2026Q2: 312,846 shares 312,846$17.9M6.32%+164,617Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 104,121 shares; 2025Q2: 197,468 shares; 2025Q3: 193,689 shares; 2025Q4: 336,849 shares; 2026Q1: 525,181 shares; 2026Q2: 441,808 shares 441,808$17.2M6.09%-83,373Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 1,359 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: not reported; 2026Q2: 272,214 shares 272,214$11.1M3.91%newTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 192,962 shares; 2026Q2: 218,117 shares 218,117$8.5M3%+25,155Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 96,984 shares; 2025Q2: 104,384 shares; 2025Q3: 124,384 shares; 2025Q4: 70,300 shares; 2026Q1: 193,189 shares; 2026Q2: 254,863 shares 254,863$8.09M2.86%+61,674Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 571,107 shares 571,107$7.6M2.68%newTimeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 165,965 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 238,142 shares; 2026Q2: 223,810 shares 223,810$6.9M2.44%-14,332Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 66,444 shares; 2026Q1: 53,771 shares; 2026Q2: 22,000 shares 22,000$5.59M1.97%-31,771Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 24,618 shares; 2025Q2: not reported; 2025Q3: 25,000 shares; 2025Q4: not reported; 2026Q1: 14,577 shares; 2026Q2: 100,000 shares 100,000$4.81M1.7%+85,423Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 244,811 shares; 2026Q2: 294,811 shares 294,811$4.4M1.56%+50,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 505,778 shares; 2025Q1: 426,346 shares; 2025Q2: 43,616 shares; 2025Q3: 43,616 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 230,677 shares 230,677$4.32M1.52%newTimeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 142,132 shares; 2026Q2: 142,132 shares 142,132$3.72M1.31%0Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 271,164 shares; 2026Q1: 60,000 shares; 2026Q2: 146,334 shares 146,334$3.59M1.27%+86,334Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 522,619 shares 522,619$3.56M1.26%newTimeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 121,539 shares 121,539$2.95M1.04%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 439,957 shares; 2026Q2: 301,264 shares 301,264$2.83M1%-138,693Timeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 71,376 shares; 2026Q2: 67,512 shares 67,512$2.77M0.98%-3,864Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 334,251 shares; 2026Q1: 352,399 shares; 2026Q2: 740,786 shares 740,786$2.73M0.96%+388,387Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 27,799 shares 27,799$2.65M0.93%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 10,000 shares; 2025Q1: 92,385 shares; 2025Q2: 198,285 shares; 2025Q3: 218,285 shares; 2025Q4: 22,972 shares; 2026Q1: 25,071 shares; 2026Q2: 45,071 shares 45,071$2.62M0.93%+20,000Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 389,395 shares; 2026Q1: 200,842 shares; 2026Q2: 361,367 shares 361,367$2.5M0.88%+160,525Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 57,608 shares 57,608$2.47M0.87%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 119,733 shares 119,733$1.96M0.69%newTimeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 476,424 shares; 2026Q2: 462,724 shares 462,724$1.96M0.69%-13,700Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 62,281 shares; 2026Q1: 187,307 shares; 2026Q2: 78,391 shares 78,391$1.9M0.67%-108,916Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 49,478 shares; 2025Q1: 162,063 shares; 2025Q2: 122,061 shares; 2025Q3: not reported; 2025Q4: 21,114 shares; 2026Q1: not reported; 2026Q2: 100,000 shares 100,000$1.84M0.65%newTimeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 600,000 shares; 2026Q2: 374,403 shares 374,403$1.73M0.61%-225,597Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 158,023 shares; 2025Q1: 207,694 shares; 2025Q2: 157,694 shares; 2025Q3: 157,694 shares; 2025Q4: 167,532 shares; 2026Q1: 180,083 shares; 2026Q2: 926,016 shares 926,016$1.72M0.61%+745,933Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares; 2026Q2: 30,000 shares 30,000$1.62M0.57%+20,000Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 252,198 shares; 2026Q1: not reported; 2026Q2: 303,025 shares 303,025$1.55M0.55%newTimeline
CUECUE BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 48,369 shares 48,369$1.53M0.54%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 26,347 shares; 2026Q2: 56,347 shares 56,347$1.52M0.54%+30,000Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,539 shares; 2026Q1: not reported; 2026Q2: 149,482 shares 149,482$1.46M0.52%newTimeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 423,642 shares; 2026Q2: 413,642 shares 413,642$1.45M0.51%-10,000Timeline
UNCYUNICYCIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 106,083 shares; 2026Q2: 303,676 shares 303,676$1.42M0.5%+197,593Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 40,294 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 54,650 shares; 2026Q2: 129,950 shares 129,950$1.41M0.5%+75,300Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,000 shares 15,000$1.33M0.47%newTimeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares 200,000$1.32M0.47%newTimeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 347,393 shares; 2026Q1: 433,844 shares; 2026Q2: 400,282 shares 400,282$1.28M0.45%-33,562Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 74,753 shares; 2025Q4: 170,568 shares; 2026Q1: 132,746 shares; 2026Q2: 132,746 shares 132,746$1.05M0.37%0Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 29,321 shares; 2026Q2: 29,321 shares 29,321$1.01M0.36%0Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 7,500 shares; 2026Q1: 92,864 shares; 2026Q2: 26,864 shares 26,864$978K0.35%-66,000Timeline
RNACCARTESIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 87,057 shares 87,057$907K0.32%newTimeline
RIGLRIGEL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: not reported; 2026Q2: 22,816 shares 22,816$893K0.32%newTimeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 932 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 60,000 shares 60,000$874K0.31%newTimeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 55,293 shares; 2026Q2: 135,293 shares 135,293$771K0.27%+80,000Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,451 shares 15,451$727K0.26%newTimeline
PTHSPELTHOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,498 shares; 2025Q4: 25,000 shares; 2026Q1: 24,773 shares; 2026Q2: 24,773 shares 24,773$700K0.25%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 150,925 shares; 2026Q2: 373,284 shares 373,284$672K0.24%+222,359Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 245 shares; 2026Q2: 10,000 shares 10,000$508K0.18%+9,755Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,690 shares; 2026Q2: 196,985 shares 196,985$469K0.17%-3,705Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 3,800 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 166,637 shares; 2026Q2: 146,637 shares 146,637$447K0.16%-20,000Timeline
CLRBCELLECTAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 138,341 shares 138,341$385K0.14%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 30,630 shares; 2026Q1: 79,944 shares; 2026Q2: 66,908 shares 66,908$327K0.12%-13,036Timeline
AYTUAYTU BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 272,670 shares; 2025Q4: 305,788 shares; 2026Q1: 353,077 shares; 2026Q2: 148,546 shares 148,546$319K0.11%-204,531Timeline
OCGNOCUGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 200,000 shares 200,000$306K0.11%0Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 50,000 shares; 2025Q1: 76,220 shares; 2025Q2: 150,000 shares; 2025Q3: 90,000 shares; 2025Q4: 21,810 shares; 2026Q1: 23,155 shares; 2026Q2: 7,137 shares 7,137$263K0.09%-16,018Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 52,100 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,701 shares 102,701$215K0.08%newTimeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 458,723 shares 458,723$196K0.07%newTimeline
TLPHTALPHERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 136,923 shares; 2026Q1: 153,563 shares; 2026Q2: 153,563 shares 153,563$158K0.06%0Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 350,000 shares; 2026Q1: 132,916 shares; 2026Q2: 27,516 shares 27,516$157K0.06%-105,400Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,630 shares; 2026Q2: 1,630 shares 1,630$151K0.05%0Timeline
LAKELAKELAND INDS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 14,108 shares 14,108$151K0.05%newTimeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,500 shares; 2026Q1: 21,609 shares; 2026Q2: 19,093 shares 19,093$132K0.05%-2,516Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,368 shares 8,368$113K0.04%newTimeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 9,021 shares 9,021$102K0.04%newTimeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,621 shares 3,621$79.8K0.03%newTimeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 212,475 shares; 2025Q4: 302,000 shares; 2026Q1: 186,603 shares; 2026Q2: 16,003 shares 16,003$68.2K0.02%-170,600Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 23,260 shares; 2026Q2: 23,260 shares 23,260$41.2K0.01%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,860 shares 4,860$38.9K0.01%newTimeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 44,907 shares 44,907$36K0.01%newTimeline
TVRDTVARDI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,185 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 16,607 shares 16,607$31.6K0.01%newTimeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 7,742 shares 7,742$12.4K<0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
VKTXVIKING THERAPEUTICS INC COMcall1,220,800$47.6M+561,600
ABVXABIVAX SA SPONSORED ADScall349,200$46.5M+249,200
BMYBRISTOL-MYERS SQUIBB CO COMcall600,000$34.6Mnew
ABVXABIVAX SA SPONSORED ADSput252,400$33.6M+152,400
BMYBRISTOL-MYERS SQUIBB CO COMput330,600$19Mnew
CORTCORCEPT THERAPEUTICS INC COMcall206,300$17.9M+47,800
KYMRKYMERA THERAPEUTICS INC COMcall149,700$17.2Mnew
NVSNOVARTIS AG ADRput100,000$15.7Mnew
QUREUNIQURE NV SHSput299,000$13.8M0
VKTXVIKING THERAPEUTICS INC COMput350,500$13.7Mnew
BIIBBIOGEN INC Stockcall60,000$13Mnew
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKput534,400$12.9M-89,000
SMMTSUMMIT THERAPEUTICS INC COMcall860,200$12.5Mnew
LLYELI LILLY & CO COMput10,000$12Mnew
INCYINCYTE CORP Stockput105,400$11.9M0
QUREUNIQURE NV SHScall235,400$10.8M-14,600
BNTXBIONTECH SE ADRcall100,000$9.3Mnew
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKcall329,300$7.93M0
NVSNOVARTIS AG ADRcall50,000$7.84Mnew
REPLREPLIMUNE GROUP INC COMMON STOCKcall696,300$7.71M+490,800
KODKODIAK SCIENCES INC COMcall196,700$7.66M+196,500
MRNAMODERNA INC COMput100,000$7M-59,400
HIMSHIMS & HERS HEALTH INC COM CL Acall200,000$6.93Mnew
HIMSHIMS & HERS HEALTH INC COM CL Aput193,700$6.72Mnew
CRBPCORBUS PHARMACEUTICALS HLDGS COM NEWcall633,800$5.95M+518,500
SLSSELLAS LIFE SCIENCES GROUP I COM NEWcall400,000$5.9M+100,000
KODKODIAK SCIENCES INC COMput146,900$5.72M-100,000
ALMSALUMIS INC COMcall200,000$5.63M+100,000
RPRXROYALTY PHARMA PLC SHS CLASS Acall100,000$5.61Mnew
REPLREPLIMUNE GROUP INC COMMON STOCKput502,500$5.56M+42,600
BIOABIOAGE LABS INC Stockcall200,100$4.9Mnew
BHVNBIOHAVEN LTD COMcall317,000$4.72M0
TENXTENAX THERAPEUTICS INC COM NEWcall307,000$4.47Mnew
TGTXTG THERAPEUTICS INC Stockcall75,700$4.16Mnew
GLUEMONTE ROSA THERAPEUTICS INC COMcall170,100$4.12Mnew
RCUSARCUS BIOSCIENCES INC COMcall124,000$3.82Mnew
UNCYUNICYCIVE THERAPEUTICS INC COMMON STOCKcall792,600$3.72Mnew
AMGNAMGEN INC COMcall10,000$3.62Mnew
NTLAINTELLIA THERAPEUTICS INC COMcall200,000$3.38M0
CLDXCELLDEX THERAPEUTICS INC NEW COM NEWput86,000$3.2Mnew
PCVXVAXCYTE INC Stockcall53,100$3.09M0
SMMTSUMMIT THERAPEUTICS INC COMput200,000$2.91Mnew
PCVXVAXCYTE INC Stockput48,900$2.84Mnew
NVONOVO-NORDISK A S ADRput55,900$2.68M0
CYTKCYTOKINETICS INC COM NEWput30,000$2.56M-170,000
VERAVERA THERAPEUTICS INC COMMON STOCKput50,000$2.15Mnew
CELCCELCUITY INC COMcall20,000$2.09M+2,300
ANNXANNEXON INC COMcall353,200$2.02M0
SEPNSEPTERNA INC Stockput59,700$2Mnew
CRVSCORVUS PHARMACEUTICALS INC COMcall133,400$1.99M+27,100
CLDXCELLDEX THERAPEUTICS INC NEW COM NEWcall50,900$1.89Mnew
ADMAADMA BIOLOGICS INC COMcall200,000$1.67Mnew
EYPTEYEPOINT INC Stockcall106,300$1.52M0
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput100,000$1.48Mnew
EOLSEVOLUS INC COMcall200,000$1.39M+74,800
CRMDCORMEDIX INC Stockput167,500$1.31M0
EDITEDITAS MEDICINE INC COMcall400,000$1.3Mnew
PYXSPYXIS ONCOLOGY INC Stockcall388,200$1.17Mnew
AQSTAQUESTIVE THERAPEUTICS INC Stockcall214,600$893Knew
HELPCYBIN INC COM NEWcall100,000$661Knew
VYGRVOYAGER THERAPEUTICS INC COMMON STOCKcall150,000$525K0
CGONCG ONCOLOGY INC COMMON STOCKcall7,300$519Knew
ELTXELICIO THERAPEUTICS INC LST Equity Optioncall112,100$438Knew
ELTXELICIO THERAPEUTICS INC LST Equity Optionput100,000$391Knew
INOINOVIO PHARMACEUTICALS INC COMMON STOCKcall275,200$303K+200,000
VTGNVISTAGEN THERAPEUTICS INC COMcall57,700$13Knew
ATYRATYR PHARMA INC COM NEWput12,500$7.46K0
MGTXMEIRAGTX HLDGS PLC COMMON STOCKcall500$6.75Knew
JBIOJADE BIOSCIENCES INC COM NEWput1,046$3.17K0
ERASERASCA INC Stockcall100$1.83Knew
CUECUE BIOPHARMA INC COMcall6$6new

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 1.750% 3/0principal250,000$18.6Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VRTXVERTEX PHARMACEUTICALS INC93,100$41.6Mcall
LQDALIQUIDIA CORPORATION662,100$25Mcall
UTHRUNITED THERAPEUTICS CORP DEL40,200$23.8Mcall
APGEAPOGEE THERAPEUTICS INC222,500$18.7Mcall
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC250,000$18.6Mshares
RVMDREVOLUTION MEDICINES INC125,500$12.2Mput
MRKMERCK & CO INC100,000$12Mput
UTHRUNITED THERAPEUTICS CORP DEL20,000$11.9Mput
JAZZJAZZ PHARMACEUTICALS PLC54,755$10.4Mshares
TERNTERNS PHARMACEUTICALS INC181,752$9.58Mshares
ROIVROIVANT SCIENCES LTD335,800$9.3Mput
INCYINCYTE CORP78,029$7.34Mshares
TGTXTG THERAPEUTICS INC206,928$6.87Mshares
EWTXEDGEWISE THERAPEUTICS INC212,500$6.69Mcall
BBIOBRIDGEBIO PHARMA INC85,311$6.34Mshares
GPCRSTRUCTURE THERAPEUTICS INC127,500$6.15Mput
LLYELI LILLY & CO6,000$5.52Mshares
ABBVABBVIE INC24,058$5.23Mshares
CRSPCRISPR THERAPEUTICS AG106,300$5.06Mcall
GPCRSTRUCTURE THERAPEUTICS INC72,234$3.48Mshares
CYTKCYTOKINETICS INC50,000$3.3Mcall
TENXTENAX THERAPEUTICS INC179,738$2.87Mshares
CAPRCAPRICOR THERAPEUTICS INC78,851$2.4Mshares
EYPTEYEPOINT INC178,545$2.3Mshares
CLYMCLIMB BIO INC286,126$1.96Mshares
STTKSHATTUCK LABS INC293,664$1.89Mshares
LQDALIQUIDIA CORPORATION50,000$1.89Mput
TARSTARSUS PHARMACEUTICALS INC25,942$1.82Mshares
ALKSALKERMES PLC50,000$1.77Mshares
VRTXVERTEX PHARMACEUTICALS INC3,840$1.71Mshares
CTMXCYTOMX THERAPEUTICS INC.316,000$1.49Mcall
AVXLANAVEX LIFE SCIENCES CORP477,600$1.47Mcall
KPTIKARYOPHARM THERAPEUTICS INC241,300$1.34Mcall
OLMAOLEMA PHARMACEUTICALS INC84,000$1.25Mcall
IOVAIOVANCE BIOTHERAPEUTICS INC300,000$1.05Mcall
INOINOVIO PHARMACEUTICALS INC562,665$979Kshares
DNTHDIANTHUS THERAPEUTICS INC10,000$839Kshares
ENTAENANTA PHARMACEUTICALS INC64,952$820Kshares
IBRXIMMUNITYBIO INC106,300$815Kput
VIRVIR BIOTECHNOLOGY INC88,800$796Kcall
REPLREPLIMUNE GROUP INC100,660$770Kshares
RAREULTRAGENYX PHARMACEUTICAL IN35,144$736Kshares
ALMSALUMIS INC31,200$687Kput
CELCCELCUITY INC5,314$607Kshares
OCGNOCUGEN INC300,000$543Kcall
QUREUNIQURE NV31,200$510Kshares
MAZEMAZE THERAPEUTICS INC15,000$448Kshares
JANXJANUX THERAPEUTICS INC31,600$439Kcall
CORTCORCEPT THERAPEUTICS INC10,000$403Kshares
LPCNLIPOCINE INC NEW50,000$400Kshares
GHRSGH RESEARCH PLC26,836$377Kshares
EPRXEUPRAXIA PHARMACEUTICALS INC40,000$290Kshares
TRVITREVI THERAPEUTICS INC21,663$258Kshares
CMPSCOMPASS PATHWAYS PLC31,885$176Kshares
PASGPASSAGE BIO INC19,530$153Kshares
RCKTROCKET PHARMACEUTICALS INC30,579$109Kshares
LYELLYELL IMMUNOPHARMA INC4,100$82.2Kput
VTGNVISTAGEN THERAPEUTICS INC105,428$60.3Kshares
RNAATRIUM THERAPEUTICS INC2,512$33.6Kshares
CUECUE BIOPHARMA INC131,997$30.3Kshares
PRTCYPURETECH HEALTH PLC7,924$11.3Kshares
IOVAIOVANCE BIOTHERAPEUTICS INC2,900$10.2Kput
ATYRATYR PHARMA INC12,200$9.52Kcall
SEPNSEPTERNA INC202$4.85Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001892688-26-000119 base2026-08-14acceptance time not in the bulk data set